首页> 外文OA文献 >Antagonism of CD317 Restriction of Human Immunodeficiency Virus Type 1 (HIV-1) Particle Release and Depletion of CD317 Are Separable Activities of HIV-1 Vpu▿
【2h】

Antagonism of CD317 Restriction of Human Immunodeficiency Virus Type 1 (HIV-1) Particle Release and Depletion of CD317 Are Separable Activities of HIV-1 Vpu▿

机译:拮抗CD317限制人类免疫缺陷病毒1型(HIV-1)的释放和CD317的消耗是HIV-1Vpu▿的独立活动。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Vpu antagonizes human immunodeficiency virus type 1 (HIV-1) particle release inhibition by CD317/BST-2/Tetherin. Whether this Vpu activity strictly requires cellular depletion of the restriction factor is unclear. Here, we characterized CD317 variants with mutations in putative sorting or ubiquitination motifs. All mutants still potently impaired release of Vpu-defective HIV-1 and remained sensitive to Vpu-mediated release enhancement. Importantly, this virological antagonism correlated with surface downregulation of CD317 mutants by Vpu, while intracellular pools of these mutants, which were consistently depleted of the wild-type protein, were highly variable or even enhanced. Thus, Vpu can efficiently antagonize virion tethering in the absence of CD317 degradation.
机译:Vpu拮抗CD317 / BST-2 / Tetherin对人类1型免疫缺陷病毒(HIV-1)颗粒释放的抑制作用。目前尚不清楚这种Vpu活性是否严格要求细胞消耗限制因子。在这里,我们表征了CD317变体的推定排序或泛素化基序中的突变。所有突变体仍然有力地损害Vpu缺陷型HIV-1的释放,并且仍然对Vpu介导的释放增强敏感。重要的是,这种病毒学拮抗作用与Vpu对CD317突变体的表面下调具有相关性,而这些突变体的细胞内池(一直被耗尽的野生型蛋白)高度可变甚至增强。因此,在不存在CD317降解的情况下,Vpu可以有效拮抗病毒体束缚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号